Ignite Creation Date:
2024-05-06 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04685616
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2020-11-27
Brief Title:
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Sponsor:
University College London
Organization:
University College London
Organization Data
Organization:
University College London
Class:
OTHER
Study ID:
RADAR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University College London
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Canadian Cancer Trials Group | NETWORK |
| Takeda | INDUSTRY |
| University of Miami | OTHER |
| European Organisation for Research and Treatment of Cancer - EORTC | NETWORK |
| Australasian Leukaemia and Lymphoma Group | OTHER |
| Seagen Inc | INDUSTRY |